Catriona Yale - Chief Development Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
AKRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Catriona Yale - trading volume in the past year for Akero Therapeutics, Inc.

Holdings reported by Catriona Yale for Akero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 91.5K $4.89M $53.47 Jul 16, 2025 Direct
Stock Option (Right to Buy) 131K Jul 16, 2025 Direct Common Stock

Transactions reported by Catriona Yale for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.